Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 187

1.

Correction: Dual Inhibition of Canonical and Noncanonical NF-κB Pathways Demonstrates Significant Antitumor Activities in Multiple Myeloma.

Fabre C, Mimura N, Bobb K, Kong SY, Gorgun G, Cirstea D, Hu Y, Minami J, Ohguchi H, Zhang J, Meshulam J, Carrasco RD, Tai YT, Richardson PG, Hideshima T, Anderson KC.

Clin Cancer Res. 2019 May 1;25(9):2938. doi: 10.1158/1078-0432.CCR-19-0959. No abstract available.

PMID:
31043386
2.

Bioactive factors secreted by Bifidobacterium breve B-3 enhance barrier function in human intestinal Caco-2 cells.

Kurose Y, Minami J, Sen A, Iwabuchi N, Abe F, Xiao J, Suzuki T.

Benef Microbes. 2019 Feb 8;10(1):89-100. doi: 10.3920/BM2018.0062. Epub 2018 Oct 24.

PMID:
30353739
3.

Clinical significance of cancer-related fatigue in multiple myeloma patients.

Suzuki K, Kobayashi N, Ogasawara Y, Shimada T, Yahagi Y, Sugiyama K, Takahara S, Saito T, Minami J, Yokoyama H, Kamiyama Y, Katsube A, Kondo K, Yanagisawa H, Aiba K, Yano S.

Int J Hematol. 2018 Dec;108(6):580-587. doi: 10.1007/s12185-018-2516-1. Epub 2018 Aug 28.

PMID:
30155589
4.

Effects of Bifidobacterium breve B-3 on body fat reductions in pre-obese adults: a randomized, double-blind, placebo-controlled trial.

Minami J, Iwabuchi N, Tanaka M, Yamauchi K, Xiao JZ, Abe F, Sakane N.

Biosci Microbiota Food Health. 2018;37(3):67-75. doi: 10.12938/bmfh.18-001. Epub 2018 May 8.

5.

Tolerance mechanisms of human-residential bifidobacteria against lysozyme.

Sakurai T, Hashikura N, Minami J, Yamada A, Odamaki T, Xiao JZ.

Anaerobe. 2017 Oct;47:104-110. doi: 10.1016/j.anaerobe.2017.05.001. Epub 2017 May 3.

PMID:
28478277
6.

Epstein-Barr Virus-associated Lymphoproliferative Disorder with Encephalitis Following Anti-thymocyte Globulin for Aplastic Anemia Resolved with Rituximab Therapy: A Case Report and Literature Review.

Mashima K, Yano S, Yokoyama H, Saito T, Machishima T, Shimada T, Yahagi Y, Takahara S, Sugiyama K, Ogasawara Y, Minami J, Kamiyama Y, Katsube A, Suzuki K, Ohshima S, Yamada H, Usui N, Aiba K.

Intern Med. 2017;56(6):701-706. doi: 10.2169/internalmedicine.56.7722. Epub 2017 Mar 17.

7.

Clinical significance of granule-containing myeloma cells in patients with newly diagnosed multiple myeloma.

Suzuki K, Yano S, Nishiwaki K, Sano K, Shimada T, Yahagi Y, Ogasawara Y, Sugiyama K, Takahara S, Saito T, Kasama K, Minami J, Yokoyama H, Kamiyama Y, Katsube A, Masuoka H, Katori M, Machishima T, Ouchi A, Dobashi N, Kaito K, Usui N, Aiba K.

Cancer Med. 2016 Nov;5(11):3051-3058. doi: 10.1002/cam4.875. Epub 2016 Oct 13.

8.

Autophagy Induced by Intracellular Infection of Propionibacterium acnes.

Nakamura T, Furukawa A, Uchida K, Ogawa T, Tamura T, Sakonishi D, Wada Y, Suzuki Y, Ishige Y, Minami J, Akashi T, Eishi Y.

PLoS One. 2016 May 24;11(5):e0156298. doi: 10.1371/journal.pone.0156298. eCollection 2016.

9.

Combination of a Selective HSP90α/β Inhibitor and a RAS-RAF-MEK-ERK Signaling Pathway Inhibitor Triggers Synergistic Cytotoxicity in Multiple Myeloma Cells.

Suzuki R, Kikuchi S, Harada T, Mimura N, Minami J, Ohguchi H, Yoshida Y, Sagawa M, Gorgun G, Cirstea D, Cottini F, Jakubikova J, Tai YT, Chauhan D, Richardson PG, Munshi N, Ando K, Utsugi T, Hideshima T, Anderson KC.

PLoS One. 2015 Dec 2;10(12):e0143847. doi: 10.1371/journal.pone.0143847. eCollection 2015.

10.

Lysozyme in breast milk is a selection factor for bifidobacterial colonisation in the infant intestine.

Minami J, Odamaki T, Hashikura N, Abe F, Xiao JZ.

Benef Microbes. 2016 Feb;7(1):53-60. doi: 10.3920/BM2015.0041. Epub 2015 Oct 27.

PMID:
26503736
11.

Comparative Genomics Revealed Genetic Diversity and Species/Strain-Level Differences in Carbohydrate Metabolism of Three Probiotic Bifidobacterial Species.

Odamaki T, Horigome A, Sugahara H, Hashikura N, Minami J, Xiao JZ, Abe F.

Int J Genomics. 2015;2015:567809. doi: 10.1155/2015/567809. Epub 2015 Jul 5.

12.

Innovative use of platinum compounds to selectively detect live microorganisms by polymerase chain reaction.

Soejima T, Minami J, Xiao JZ, Abe F.

Biotechnol Bioeng. 2016 Feb;113(2):301-10. doi: 10.1002/bit.25711. Epub 2015 Aug 19.

PMID:
26192088
13.

Propionibacterium acnes catalase induces increased Th1 immune response in sarcoidosis patients.

Yorozu P, Furukawa A, Uchida K, Akashi T, Kakegawa T, Ogawa T, Minami J, Suzuki Y, Awano N, Furusawa H, Miyazaki Y, Inase N, Eishi Y.

Respir Investig. 2015 Jul;53(4):161-9. doi: 10.1016/j.resinv.2015.02.005. Epub 2015 May 23.

PMID:
26100176
14.

Oral administration of Bifidobacterium breve B-3 modifies metabolic functions in adults with obese tendencies in a randomised controlled trial.

Minami J, Kondo S, Yanagisawa N, Odamaki T, Xiao JZ, Abe F, Nakajima S, Hamamoto Y, Saitoh S, Shimoda T.

J Nutr Sci. 2015 May 4;4:e17. doi: 10.1017/jns.2015.5. eCollection 2015.

15.

Effects of daily walking on office, home and 24-h blood pressure in hypertensive patients.

Ohta Y, Kawano Y, Minami J, Iwashima Y, Hayashi S, Yoshihara F, Nakamura S.

Clin Exp Hypertens. 2015;37(5):433-7. doi: 10.3109/10641963.2015.1013115. Epub 2015 Mar 27.

PMID:
25815710
16.

Anti-tumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma.

Suzuki R, Hideshima T, Mimura N, Minami J, Ohguchi H, Kikuchi S, Yoshida Y, Gorgun G, Cirstea D, Cottini F, Jakubikova J, Tai YT, Chauhan D, Richardson PG, Munshi NC, Utsugi T, Anderson KC.

Leukemia. 2015 Feb;29(2):510-4. doi: 10.1038/leu.2014.300. Epub 2014 Oct 13. No abstract available.

17.

Selective and potent Akt inhibition triggers anti-myeloma activities and enhances fatal endoplasmic reticulum stress induced by proteasome inhibition.

Mimura N, Hideshima T, Shimomura T, Suzuki R, Ohguchi H, Rizq O, Kikuchi S, Yoshida Y, Cottini F, Jakubikova J, Cirstea D, Gorgun G, Minami J, Tai YT, Richardson PG, Utsugi T, Iwama A, Anderson KC.

Cancer Res. 2014 Aug 15;74(16):4458-69. doi: 10.1158/0008-5472.CAN-13-3652. Epub 2014 Jun 16.

18.

Histone deacetylase 3 as a novel therapeutic target in multiple myeloma.

Minami J, Suzuki R, Mazitschek R, Gorgun G, Ghosh B, Cirstea D, Hu Y, Mimura N, Ohguchi H, Cottini F, Jakubikova J, Munshi NC, Haggarty SJ, Richardson PG, Hideshima T, Anderson KC.

Leukemia. 2014 Mar;28(3):680-9. doi: 10.1038/leu.2013.231. Epub 2013 Aug 5.

19.

The exclusive use of flow cytometry to evaluate the antibiotic-susceptibility.

Soejima T, Minami J, Iwatsuki K.

Biochim Biophys Acta. 2012 Dec;1820(12):1980-6. doi: 10.1016/j.bbagen.2012.09.003. Epub 2012 Sep 12.

PMID:
22982588
20.

Direct real-time PCR with ethidium monoazide: a method for the rapid detection of viable Cronobacter sakazakii in powdered infant formula.

Minami J, Soejima T, Yaeshima T, Iwatsuki K.

J Food Prot. 2012 Sep;75(9):1572-9. doi: 10.4315/0362-028X.JFP-12-015.

PMID:
22947463
21.

Dual inhibition of canonical and noncanonical NF-κB pathways demonstrates significant antitumor activities in multiple myeloma.

Fabre C, Mimura N, Bobb K, Kong SY, Gorgun G, Cirstea D, Hu Y, Minami J, Ohguchi H, Zhang J, Meshulam J, Carrasco RD, Tai YT, Richardson PG, Hideshima T, Anderson KC.

Clin Cancer Res. 2012 Sep 1;18(17):4669-81. doi: 10.1158/1078-0432.CCR-12-0779. Epub 2012 Jul 17. Erratum in: Clin Cancer Res. 2019 May 1;25(9):2938.

22.

Rapid propidium monoazide PCR assay for the exclusive detection of viable Enterobacteriaceae cells in pasteurized milk.

Soejima T, Minami J, Iwatsuki K.

J Dairy Sci. 2012 Jul;95(7):3634-42. doi: 10.3168/jds.2012-5360.

23.

An advanced PCR method for the specific detection of viable total coliform bacteria in pasteurized milk.

Soejima T, Minami J, Yaeshima T, Iwatsuki K.

Appl Microbiol Biotechnol. 2012 Jul;95(2):485-97. doi: 10.1007/s00253-012-4086-0. Epub 2012 May 30.

PMID:
22644523
24.

Localization of propionibacterium acnes in granulomas supports a possible etiologic link between sarcoidosis and the bacterium.

Negi M, Takemura T, Guzman J, Uchida K, Furukawa A, Suzuki Y, Iida T, Ishige I, Minami J, Yamada T, Kawachi H, Costabel U, Eishi Y.

Mod Pathol. 2012 Sep;25(9):1284-97. doi: 10.1038/modpathol.2012.80. Epub 2012 May 18.

25.

Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma.

Mimura N, Fulciniti M, Gorgun G, Tai YT, Cirstea D, Santo L, Hu Y, Fabre C, Minami J, Ohguchi H, Kiziltepe T, Ikeda H, Kawano Y, French M, Blumenthal M, Tam V, Kertesz NL, Malyankar UM, Hokenson M, Pham T, Zeng Q, Patterson JB, Richardson PG, Munshi NC, Anderson KC.

Blood. 2012 Jun 14;119(24):5772-81. doi: 10.1182/blood-2011-07-366633. Epub 2012 Apr 26.

26.

QT dispersion and rate-corrected QT dispersion during electroconvulsive therapy in elderly patients.

Yamaguchi S, Nagao M, Ikeda T, Fukagawa D, Kimura Y, Kitajima T, Minami J.

J ECT. 2011 Sep;27(3):183-8. doi: 10.1097/YCT.0b013e31822145bd.

PMID:
21865956
27.

Combination of angiotensin II receptor antagonist with calcium channel blocker or diuretic as antihypertensive therapy for patients with chronic kidney disease.

Ishimitsu T, Ohno E, Nakano N, Furukata S, Akashiba A, Minami J, Numabe A, Matsuoka H.

Clin Exp Hypertens. 2011;33(6):366-72. doi: 10.3109/10641963.2010.503299. Epub 2011 Jul 28.

PMID:
21797795
28.

Rapid progression and unusual premortal diagnosis of mucormycosis in patients with hematologic malignancies: analysis of eight patients.

Yano S, Minami J, Nishiwaki K, Shimada T, Dobashi N, Yahagi Y, Takei Y, Takahara S, Ogasawara Y, Sugiyama K, Yamaguchi Y, Saito T, Kasama K, Yokoyama H, Machishima T, Katsube A, Usui N, Aiba K.

Int J Hematol. 2011 Mar;93(3):344-350. doi: 10.1007/s12185-011-0780-4. Epub 2011 Mar 2.

PMID:
21365229
29.

Two cases of mediastinal gray zone lymphoma.

Minami J, Dobashi N, Asai O, Yano S, Osawa H, Takei Y, Yahagi Y, Takahara S, Ogasawara Y, Yamaguchi Y, Kobayashi T, Morikawa N, Nikaido T, Aiba K, Usui N.

J Clin Exp Hematop. 2010;50(2):143-9.

30.

[High-dose methotrexate followed by whole-brain irradiation for primary central nervous system lymphoma patients--a retrospective study in a single institute].

Usui N, Dobashi N, Yano S, Yahagi Y, Takei Y, Otsubo H, Takahara S, Yamaguchi Y, Saito T, Minami J, Kamiyama Y, Morikawa N, Machishima T, Osawa H, Aiba K.

Gan To Kagaku Ryoho. 2010 Jul;37(7):1277-82. Japanese.

PMID:
20647709
31.

New approach to use ethidium bromide monoazide as an analytical tool.

Minami J, Yoshida K, Soejima T, Yaeshima T, Iwatsuki K.

J Appl Microbiol. 2010 Sep;109(3):900-9. doi: 10.1111/j.1365-2672.2010.04716.x.

32.

Assessment of QT interval and QT dispersion during electroconvulsive therapy using computerized measurements.

Tezuka N, Egawa H, Fukagawa D, Yamaguchi S, Hamaguchi S, Kitajima T, Minami J.

J ECT. 2010 Mar;26(1):41-6. doi: 10.1097/YCT.0b013e3181a95dbe.

PMID:
20190602
33.

Effects of landiolol on QT interval and QT dispersion during induction of anesthesia using computerized measurement.

Kaneko M, Yamaguchi S, Hamaguchi S, Egawa H, Fujii K, Ishikawa K, Kitajima T, Minami J.

J Clin Anesth. 2009 Dec;21(8):555-61. doi: 10.1016/j.jclinane.2008.12.027.

PMID:
20122586
34.

Fractionated administration of gemtuzumab ozogamicin for refractory acute myeloid leukemia.

YAHAGI Y, USUI N, YAMAGUCHI Y, DOBASHI N, YANO S, TAKEI Y, SUGIYAMA K, TAKAHARA S, SAITO T, MINAMI J, KOBAYASHI T, KAMIYAMA Y, MORIKAWA T, AIBA K.

Rinsho Ketsueki. 2009 Nov;50(11):1601-6.

PMID:
20009433
36.

Retrospective comparison of mobilization methods for autologous stem cell transplantation in multiple myeloma.

Nakasone H, Kanda Y, Ueda T, Matsumoto K, Shimizu N, Minami J, Sakai R, Hagihara M, Yokota A, Oshima K, Tsukada Y, Tachibana T, Nakaseko C, Fujisawa S, Yano S, Fujita H, Takahashi S, Kanamori H, Okamoto S; Kanto Study Group of Cell Therapy.

Am J Hematol. 2009 Dec;84(12):809-14. doi: 10.1002/ajh.21552.

37.

Purification and characterization of a clostripain-like protease from a recombinant Clostridium perfringens culture.

Manabe S, Nariya H, Miyata S, Tanaka H, Minami J, Suzuki M, Taniguchi Y, Okabe A.

Microbiology. 2010 Feb;156(Pt 2):561-9. doi: 10.1099/mic.0.031609-0. Epub 2009 Oct 22.

PMID:
19850615
38.

Angiotensin-II receptor antagonist combined with calcium channel blocker or diuretic for essential hypertension.

Ishimitsu T, Numabe A, Masuda T, Akabane T, Okamura A, Minami J, Matsuoka H.

Hypertens Res. 2009 Nov;32(11):962-8. doi: 10.1038/hr.2009.133. Epub 2009 Aug 21.

PMID:
19696778
39.

Gemtuzumab ozogamicin (GO) in relapsed/refractory patients with acute myeloid leukemia.

Yamaguchi Y, Usui N, Dobashi N, Yano S, Yahagi Y, Takei Y, Sugiyama K, Ogasawara Y, Saito T, Minami J, Kobayashi T, Katsube A, Kamiyama Y, Machishima T, Morikawa N, Otsubo H, Kaito K, Asai O, Aiba K.

Gan To Kagaku Ryoho. 2009 Jul;36(7):1105-9.

PMID:
19620797
40.

Pretreatment levels of plasma renin activity predict ambulatory blood pressure response to valsartan in essential hypertension.

Minami J, Ohno E, Furukata S, Ishimitsu T, Matsuoka H.

J Hum Hypertens. 2009 Oct;23(10):683-6. doi: 10.1038/jhh.2009.31. Epub 2009 Apr 16. No abstract available.

PMID:
19369955
41.

Association of smoking with aortic wave reflection and central systolic pressure and metabolic syndrome in normotensive Japanese men.

Minami J, Ishimitsu T, Ohrui M, Matsuoka H.

Am J Hypertens. 2009 Jun;22(6):617-23. doi: 10.1038/ajh.2009.62. Epub 2009 Mar 26.

PMID:
19325535
43.

Birth weight and risk of type 2 diabetes: a systematic review.

Whincup PH, Kaye SJ, Owen CG, Huxley R, Cook DG, Anazawa S, Barrett-Connor E, Bhargava SK, Birgisdottir BE, Carlsson S, de Rooij SR, Dyck RF, Eriksson JG, Falkner B, Fall C, Forsén T, Grill V, Gudnason V, Hulman S, Hyppönen E, Jeffreys M, Lawlor DA, Leon DA, Minami J, Mishra G, Osmond C, Power C, Rich-Edwards JW, Roseboom TJ, Sachdev HS, Syddall H, Thorsdottir I, Vanhala M, Wadsworth M, Yarbrough DE.

JAMA. 2008 Dec 24;300(24):2886-97. doi: 10.1001/jama.2008.886. Review.

PMID:
19109117
44.

A case of primary esophageal mucosa-associated lymphoid tissue lymphoma with a numerical abnormality of 18q21 detected by fluorescence in situ hybridization.

Yano S, Usui N, Dobashi N, Yahagi Y, Takahara S, Sugiyama K, Ogasawara Y, Saito T, Minami J, Kobayashi T, Nikaido T, Takeuchi K, Aiba K.

Ann Hematol. 2009 Jul;88(7):703-4. doi: 10.1007/s00277-008-0653-y. Epub 2008 Dec 4. No abstract available.

PMID:
19052745
45.

Predictive significance of blood pressure values for the incidence of cardiovascular events in chronic hemodialysis patients.

Ishimitsu T, Nakano N, Sudo Y, Akashiba A, Takahashi T, Ohta S, Minami J, Matsuoka H.

Hypertens Res. 2008 Sep;31(9):1703-9. doi: 10.1291/hypres.31.1703.

PMID:
18971548
46.

[Chronic kidney disease (CKD) as an independent risk factor for cardiovascular disease (CVD)].

Minami J, Ishimitsu T, Sudo Y, Matsuoka H.

Nihon Rinsho. 2008 Sep;66(9):1657-63. Review. Japanese.

PMID:
18788391
47.

Effects of functional polymorphisms related to catecholaminergic systems on changes in blood catecholamine and cardiovascular measures after alcohol ingestion in the Japanese population.

Nishimura FT, Kimura Y, Abe S, Fukunaga T, Minami J, Tanii H, Saijoh K.

Alcohol Clin Exp Res. 2008 Nov;32(11):1937-46. doi: 10.1111/j.1530-0277.2008.00778.x. Epub 2008 Aug 18.

PMID:
18715275
48.

Is there overlap in blood-pressure response to the blockers of the renin-angiotensin system between lower and higher renin subjects?

Minami J, Ishimitsu T, Matsuoka H.

Am J Hypertens. 2008 Feb;21(2):130-1; author reply 132. doi: 10.1038/ajh.2007.40. No abstract available.

PMID:
18268482
49.

Elevated serum levels of human matrix metalloproteinase-9 (MMP-9) during the induction of peripheral blood stem cell mobilization by granulocyte colony-stimulating factor (G-CSF).

Saito T, Usui N, Asai O, Dobashi N, Yano S, Osawa H, Takei Y, Takahara S, Ogasawara Y, Otsubo H, Yamaguchi Y, Minami J, Hoshi Y, Kataoka M, Aiba K.

J Infect Chemother. 2007 Dec;13(6):426-8. Epub 2007 Dec 25.

PMID:
18095095
50.

Supplemental Content

Loading ...
Support Center